HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-related HCC with distinct features
Introduction: A set of genetic mutations to classify hepatocellular carcinoma (HCC) useful to clinical studies is an unmet need. Hepatitis B virus-related HCC (HBV-HCC) harbors a unique genetic mutation, namely the HBV integration, among other somatic endogenous gene mutations. We explored a combina...
Main Authors: | Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, Ming-Chih Ho, Chi-Ling Chen, Tung-Ching Ho, Yung-Feng Lin, Shih-Feng Tsai, Sheng-Tai Tzeng, Chin-Fang Huang, Ya-Chun Wang, Shiou-Hwei Yeh, Pei-Jer Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-04-01
|
Series: | Liver Cancer |
Online Access: | https://www.karger.com/Article/FullText/530699 |
Similar Items
-
Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCCSummary
by: Shiou-Hwei Yeh, et al.
Published: (2023-01-01) -
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022-06-01) -
Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC
by: Jiao Meng, et al.
Published: (2024-03-01) -
Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
by: Anthony Tanoto Tan, et al.
Published: (2022-04-01) -
The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
by: Xiao-Zhen Kang, et al.
Published: (2018-07-01)